Breast Cancer Treatment Studies

Breast cancer is not a single disease but a collection of molecularly distinct subtypes, each defined by patterns of gene expression and the presence or absence of hormone receptors, that respond differently to treatment. Researchers study how these molecular profiles predict whether a tumour will shrink in response to neoadjuvant chemotherapy or radiotherapy given before surgery, with the goal of tailoring treatment to the individual patient rather than applying a one-size-fits-all protocol. A central challenge is identifying reliable prognostic markers — measurable biological signals that can tell clinicians early on which patients are likely to achieve remission and which face higher relapse risk. Active work focuses on refining the classification of molecular subtypes, understanding the mechanisms behind treatment resistance, and translating laboratory findings into clinical practice guidelines that improve long-term survival.

Works

119,692

Total citations

2,019,091

Keywords

Gene ExpressionBreast TumoursTreatment ResponseMolecular SubtypesPrognostic MarkersNeoadjuvant Therapy